Document is current
Any future updates will be listed below
-
Authors
Mura, Rebecca
Kifjak, Daria
Beer, Lucian
Prosch, Helmut
-
Funding
Funding for this research was provided by:
Medical University of Vienna
- License Information
-
More Information
Article History
Received: 17 September 2025
Accepted: 5 December 2025
First Online: 19 December 2025
Conflict of interest
: L. Beer: Speaker honoraria: AstraZeneca, MSD, Novartis, Roche, Bayer; H. Prosch: Speaker honoraria: AstraZeneca, BMS, Boehringer Ingelheim, Janssen, MSD, Novartis, Roche, Sanofi, Siemens Healthcare, Takeda. Advisory Boards: BMS, Boehringer Ingelheim, MSD, Roche/Intermune, Sanofi. Travel grants: Boehringer Ingelheim. Research support: Boehringer Ingelheim, AstraZeneca, Siemens Healthineers, Austrian Federal Ministry for Labour and Economy, the National Foundation for Research, Technology and Development and the Christian Doppler Research Association, EU Commission (EU4Health, Horizon Europe Health). R. Mura and D. Kifjak, declare that they have no competing interests.
